[{"address1": "2440 Research Boulevard", "address2": "Suite 400", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "240 745 6330", "website": "https://www.i-mabbiopharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "I-Mab, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. I-Mab was founded in 2014 and is headquartered in Rockville, Maryland.", "fullTimeEmployees": 32, "companyOfficers": [{"maxAge": 1, "name": "Mr. Wei  Fu", "age": 42, "title": "Executive Chairman", "yearBorn": 1982, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Xi-Yong  Fu M.B.A., Ph.D.", "age": 52, "title": "CEO & Director", "yearBorn": 1972, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Skelton  Joseph", "age": 33, "title": "Chief Financial Officer", "yearBorn": 1991, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tyler  Ehler", "title": "Senior Director of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Claire  Xu M.D., Ph.D.", "title": "Senior Vice President of Clinical Development", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Phillip  Dennis M.D., Ph.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1963, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sean Wuxiong Cao M.B.A., Ph.D.", "title": "Chief Business Development Officer & Independent Director", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.56, "open": 6.3, "dayLow": 4.86, "dayHigh": 6.39, "regularMarketPreviousClose": 6.56, "regularMarketOpen": 6.3, "regularMarketDayLow": 4.86, "regularMarketDayHigh": 6.39, "payoutRatio": 0.0, "beta": 1.458, "forwardPE": -3.92517, "volume": 4094722, "regularMarketVolume": 4094722, "averageVolume": 2610087, "averageVolume10days": 2742520, "averageDailyVolume10Day": 2742520, "bid": 4.56, "ask": 6.25, "bidSize": 2, "askSize": 2, "marketCap": 665085120, "fiftyTwoWeekLow": 0.595, "fiftyTwoWeekHigh": 6.79, "allTimeHigh": 85.4, "allTimeLow": 0.595, "fiftyDayAverage": 4.4148, "twoHundredDayAverage": 2.12609, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 923251200, "profitMargins": 0.0, "floatShares": 97820014, "sharesOutstanding": 115266053, "sharesShort": 2633336, "sharesShortPriorMonth": 1982444, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.0228, "heldPercentInsiders": 0.21398, "heldPercentInstitutions": 0.20056999, "shortRatio": 1.8, "shortPercentOfFloat": 0.0286, "impliedSharesOutstanding": 82623296, "bookValue": 2.405, "priceToBook": 2.3991685, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -39990000, "trailingEps": -0.51, "forwardEps": -1.47, "enterpriseToEbitda": -24.242, "52WeekChange": 3.1811595, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 5.77, "targetHighPrice": 10.0, "targetLowPrice": 6.0, "targetMeanPrice": 8.16667, "targetMedianPrice": 8.5, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 165614000, "totalCashPerShare": 0.88, "ebitda": -38085000, "totalDebt": 3481000, "quickRatio": 22.648, "currentRatio": 22.817, "debtToEquity": 1.769, "returnOnAssets": -0.10358, "returnOnEquity": -0.18456, "freeCashflow": -7126875, "operatingCashflow": 43591000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMAB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1760743486, "regularMarketTime": 1760731201, "exchange": "NGM", "messageBoardId": "finmb_642067965", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -12.0427, "regularMarketPrice": 5.77, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1579271400000, "shortName": "I-MAB", "longName": "I-Mab", "postMarketChangePercent": -0.519934, "postMarketPrice": 5.74, "postMarketChange": -0.0300002, "regularMarketChange": -0.79, "regularMarketDayRange": "4.86 - 6.39", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 2610087, "fiftyTwoWeekLowChange": 5.175, "fiftyTwoWeekLowChangePercent": 8.697479, "fiftyTwoWeekRange": "0.595 - 6.79", "fiftyTwoWeekHighChange": -1.02, "fiftyTwoWeekHighChangePercent": -0.15022092, "fiftyTwoWeekChangePercent": 318.11594, "earningsTimestamp": 1755144000, "earningsTimestampStart": 1762950600, "earningsTimestampEnd": 1762950600, "earningsCallTimestampStart": 1724846400, "earningsCallTimestampEnd": 1724846400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.51, "epsForward": -1.47, "epsCurrentYear": -0.31333, "priceEpsCurrentYear": -18.41509, "fiftyDayAverageChange": 1.3551998, "fiftyDayAverageChangePercent": 0.3069674, "twoHundredDayAverageChange": 3.64391, "twoHundredDayAverageChangePercent": 1.713902, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]